Christina Farr is the editor-in-chief/CEO of Second Opinion, and a GP at early-stage healthcare fund Scrub Capital.
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!